A-620223, CAS [[272769-49-0]]

Produktübersicht

• Artikelname: A-620223, CAS [[272769-49-0]]
• Artikelnummer: MCE-HY-10615
• Hersteller Artikelnummer: HY-10615
• Alternativnummer: MCE-HY-10615-25MG,MCE-HY-10615-10MG,MCE-HY-10615-5MG,MCE-HY-10615-100MG,MCE-HY-10615-50MG
• Hersteller: MedchemExpress
• Kategorie: Biochemikalien

Produktbeschreibung

A-620223 is a PARP-1 inhibitor with a Ki of 8 nM against PARP-1 and EC50 of 3 nM in a whole cell assay. A-620223 demonstrates good in vivo efficacy in a B16F10 subcutaneous murine melanoma model in combination with Temozolomide (TMZ) (HY-17364) and in an MX-1 breast xenograph model in combination with Cisplatin (HY-17394). A-620223 can be used for the studies of melanoma and breast cancer[1].

Produkteigenschaften

• Molekulargewicht: 286.37
• Reinheit: 98.84
• CAS Nummer: [272769-49-0]
• Formel: C16H22N4O
• Target-Kategorie: PARP

Anwendungsbeschreibung

• Anwendungsbeschreibung: MCE Product type: Reference compound